Interestingly, several studies have also shown an association between the elevated expression of CB1R and/or CB2R and a better prognosis in hepatocellular carcinoma [99], ERα− and ERα+ breast cancer [66], and non-small-cell lung cancer [60]. This evidence concerns the gene CNR1 and hepatocellular carcinoma.